B cell receptor (surface immunoglobulin) and host antibody (BCR (for B cell receptor))

The **B cell receptor (BCR)** is a transmembrane protein complex on the surface of B lymphocytes that mediates antigen recognition and triggers signaling pathways leading to B cell activation, proliferation, and differentiation[1][2][4]. Structurally, it consists of membrane-bound immunoglobulin molecules (each with two identical heavy and light chains) associated with the Igα and Igβ signaling subunits[1][2][4][6]. Upon antigen binding, the BCR clusters and initiates signal transduction via immunoreceptor tyrosine-based activation motifs (ITAMs), leading to cellular responses essential for antibody-mediated immunity[1][2][4].\n\n**Host antibodies** (also called immunoglobulins) are the soluble, secreted proteins produced by plasma cells differentiated from activated B cells[3][6]. These antibodies bind and neutralize specific antigens, facilitate pathogen clearance via opsonization and complement activation, and serve as key components for diagnostic and therapeutic uses in infection, autoimmunity, and oncology[3][5].\n\nBoth B cell receptors and host antibodies are fundamental to the adaptive immune response: B cell receptors initiate the humoral immune response through antigen binding and signaling, while antibodies execute effector functions following their production and secretion[3][6]. Dysregulation or aberrant activation in either component can contribute to diseases such as B cell malignancies, autoimmunity, or immunodeficiency[7]. Therapeutic targeting of these molecules is common in cancer, autoimmune conditions, and as direct intervention in infectious disease.

Other names

BCRSurface immunoglobulinImmunoglobulin (for antibodies)Membrane-bound antibodyAntibody (for secreted form)

Inhibition of B cell receptor signaling (small-molecule inhibitors like ibrutinib); Depletion of B cells (anti-CD20 monoclonal antibodies); Direct neutralization or opsonization of pathogens/cancer cells (therapeutic antibodies); Blocking antigen-receptor interaction; Inhibition of antibody production